Biotech startup Retro Biosciences is undertaking a one-of-a-kind experiment housed in shipping containers, funded by a $180 (£142.78) million investment by tech leader Sam Altman to increase lifespan.
Altman, the 38-year-old tech heavyweight, has been a significant player in the industry. Despite his young age, Altman took the tech realm by storm with offerings like ChatGPT and Sora. Unsurprisingly, his involvement in these groundbreaking projects has propelled him to a level of influence rivaling Mark Zuckerberg and Elon Musk, who is currently embroiled in a lawsuit with OpenAI.
